APA

Van Hecken A., Schwartz J. I., Depré M., De Lepeleire I., Dallob A., Tanaka W., Wynants K., Buntinx A., Arnout J., Wong P. H., Ebel D. L., Gertz B. J. & De Schepper P. J. (20010201). Comparative inhibitory activity of rofecoxib, meloxicam, diclofenac, ibuprofen, and naproxen on COX-2 versus COX-1 in healthy volunteers. : Journal of clinical pharmacology.

Chicago

Van Hecken A, Schwartz J I, Depré M, De Lepeleire I, Dallob A, Tanaka W, Wynants K, Buntinx A, Arnout J, Wong P H, Ebel D L, Gertz B J and De Schepper P J. 20010201. Comparative inhibitory activity of rofecoxib, meloxicam, diclofenac, ibuprofen, and naproxen on COX-2 versus COX-1 in healthy volunteers. : Journal of clinical pharmacology.

Harvard

Van Hecken A., Schwartz J. I., Depré M., De Lepeleire I., Dallob A., Tanaka W., Wynants K., Buntinx A., Arnout J., Wong P. H., Ebel D. L., Gertz B. J. and De Schepper P. J. (20010201). Comparative inhibitory activity of rofecoxib, meloxicam, diclofenac, ibuprofen, and naproxen on COX-2 versus COX-1 in healthy volunteers. : Journal of clinical pharmacology.

MLA

Van Hecken A, Schwartz J I, Depré M, De Lepeleire I, Dallob A, Tanaka W, Wynants K, Buntinx A, Arnout J, Wong P H, Ebel D L, Gertz B J and De Schepper P J. Comparative inhibitory activity of rofecoxib, meloxicam, diclofenac, ibuprofen, and naproxen on COX-2 versus COX-1 in healthy volunteers. : Journal of clinical pharmacology. 20010201.